Hematology NewsCD22 CAR activity in B-ALL highlights promise of multispecific CARsNovember 21, 2017ALLImmuno-oncologyLymphoma & Plasma Cell Disorders
Hematology NewsCAR T-cell therapy: Moving from cost to valueNovember 21, 2017ALLAggressive LymphomasImmuno-oncology
Oncology PracticeFDA authorizes next-generation sequencing test for tumor profilingNovember 17, 2017Immuno-oncologyTranslational Research
Oncology PracticeNCI-MATCH: Nivolumab shows promising activity in noncolorectal cancersNovember 15, 2017Immuno-oncologyAggressive LymphomasGynecologic CancerGenitourinary CancerBreast Cancer
Oncology PracticeGut bacteria influenced response to checkpoint inhibitorsNovember 14, 2017Immuno-oncologyMelanomaLung CancerGenitourinary Cancer
Oncology PracticeCheckMate 214: Updated results for RCC focus on PD-L1 expression, QOLNovember 13, 2017Renal Cell CarcinomaImmuno-oncology
Oncology PracticeNeoantigen profiling predicts response to immunotherapyNovember 8, 2017Immuno-oncologyLung CancerMelanomaGastroenterologyGastrointestinal Cancer
Oncology PracticeNivolumab linked to CNS disorder in case reportNovember 2, 2017Immuno-oncologyPatient & Survivor CareAggressive Lymphomas
Hematology NewsFDA approves second CAR-T therapyOctober 19, 2017Aggressive LymphomasLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Oncology PracticeKeynote 040: Pembrolizumab misses efficacy endpoint in advanced HNSCCOctober 17, 2017Immuno-oncologyHead & Neck/Thyroid Cancers
Hematology NewsCascade of costs could push new gene therapy above $1 million per patientOctober 17, 2017ALLImmuno-oncologyLeukemia, Myelodysplasia, Transplantation
Oncology PracticeLiquid biopsy predicts checkpoint inhibitor responseOctober 2, 2017Immuno-oncologyLung CancerMelanomaHead & Neck/Thyroid Cancers
Oncology PracticeCheckmate 214: Upfront nivo/ipi bests TKI in advanced RCCSeptember 28, 2017Renal Cell CarcinomaImmunotherapyImmuno-oncology
Oncology PracticeFDA approves pembrolizumab for gastric and GEJ adenocarcinomaSeptember 27, 2017GastroenterologyImmuno-oncologyGI OncologyGastrointestinal Cancer
Oncology PracticeRetrospective review: No difference in PFS, OS with radiation before PD-1/PD-L1 inhibitionSeptember 26, 2017Lung CancerImmuno-oncology
